Medtronic PLC
MDT Healthcare Medical Devices
Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025. In the quarter to July 2026, revenue grew 13.7%, EPS grew 42.0%, free cash flow grew 120.9% and total debt fell 1.59%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three.
Follow MDT
Medtronic PLC (MDT) EV/Sales
As of 16 October 2026, Medtronic PLC (MDT) trades at a EV/Sales of 3.7×. Over the past ten years it has ranged from 3.1× (June 2026) to 6.9× (April 2021); the current reading is higher than 7% of that period. That is above the Medical Devices industry median of 2.2× and above the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2026 | 3.4× | (12.07%) |
| FY2025 | 3.8× | 0.38% |
| FY2024 | 3.8× | (12.98%) |
| FY2023 | 4.4× | (8.55%) |
| FY2022 | 4.8× | (24.62%) |
| FY2021 | 6.4× | 27.11% |
| FY2020 | 5.0× | 13.27% |
| FY2019 | 4.4× | 7.42% |
| FY2018 | 4.1× | (9.59%) |
| FY2017 | 4.6× | 0.68% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jul 2026 | 3.4× | 1.67% |
| Apr 2026 | 3.4× | (21.04%) |
| Jan 2026 | 4.3× | 8.23% |
| Oct 2025 | 3.9× | (0.95%) |
| 43 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| PHG Koninklijke Philips N.V. compare | 1.4× |
| GEHC GE HealthCare Technologies Inc. compare | 1.9× |
| BSX Boston Scientific Corporation compare | 3.7× |
| MDT Medtronic PLC | 3.7× |
| STE STERIS plc compare | 3.8× |
| ABT Abbott Laboratories compare | 4.5× |
| SYK Stryker Corporation compare | 4.8× |
| DXCM DexCom, Inc. compare | 6.6× |
| EW Edwards Lifesciences Corporation compare | 7.2× |
| Medical Devices industry median | 2.2× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on MDT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement